Skip to main navigation

Corporate Site Careers

MedAvail
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
X
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
MedAvail

News Releases

May 18, 2023
MedAvail Reports First Quarter 2023 Financial Results
PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023 . “During the first quarter, we made good progress toward our mission of becoming a
May 18, 2023
MedAvail to Report First Quarter 2023 Financial Results on May 18
Management to host investor conference call and webcast at 4:30pm EDT today PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first
May 15, 2023
MedAvail Postpones Reporting of First Quarter 2023 Financial Results
PHOENIX , May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the quarter ended March 31, 2023 previously
April 13, 2023
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
PHOENIX , April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022 . “Since assuming the role of CEO in January 2022 , I have been
April 12, 2023
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
Management to host investor conference call and webcast at 4:30pm EDT on that day PHOENIX , April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the
March 30, 2023
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
PHOENIX , March 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the fourth quarter and full-year ended December
March 16, 2023
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Management to host investor conference call and webcast at 4:30pm ET on that day PHOENIX , March 16, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the
March 14, 2023
MedAvail Announces Closing of $16 Million Private Placement
PHOENIX , March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that on March 13, 2023 , it closed a private placement (the “Offering”) of securities with certain institutional investors pursuant to the
January 26, 2023
MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy
PHOENIX , Jan. 26, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative technology-enabled pharmacy company, today announced it has entered into a definitive agreement with CVS Pharmacy, Inc. , on behalf of itself and its subsidiaries and affiliates (“CVS”),
January 19, 2023
MedAvail announces Strategic Restructuring of Business to Focus on Profitability
Company focusing on innovative technology and exit of pharmacy services Restructuring to further extend capital resources Annual cash burn expected to be reduced by greater than 65% in 2023 Company exploring financing options in connection with business transition PHOENIX, Ariz. , Jan.
MedAvail

1.877.830.0826
info@medavail.com
ir@medavail.com

Home office:
4720 E. Cotton Gin Loop
Suite 220
Phoenix, AZ 85040

Canada office:
6665 Millcreek Dr. Unit 1
Mississauga, ON L5N 5M4 Canada

  • For pharmacies
  • For physician groups
  • The MedCenter
  • Partners
  • Investor Relations
  • About MedAvail
  • Careers
  • In the news
  • Contact MedAvail

Sorry. You must be logged in to view this form.

Footer Nav 2

  • Regulatory Compliance
  • Privacy Policy
  • Patent and Trademark Notice
  • Accessibility
Menu

© 2023 MedAvail Technologies, Inc. All rights reserved.